Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 14:10:20503121221110079.
doi: 10.1177/20503121221110079. eCollection 2022.

Evaluation of the performance of Panbio™ COVID-19 antigen rapid diagnostic test for the detection of SARS-CoV-2 in suspected patients in Ethiopia

Affiliations

Evaluation of the performance of Panbio™ COVID-19 antigen rapid diagnostic test for the detection of SARS-CoV-2 in suspected patients in Ethiopia

Dejene Dessalegn et al. SAGE Open Med. .

Abstract

Objective: Reverse transcription-polymerase chain reaction is a gold standard diagnostic tool for coronavirus disease-2019. Limited coverage and long turnaround times are linked to the poor response to the pandemic in developing countries like Ethiopia. To overcome the challenges, rapid antigen diagnostic kits are recommended if their diagnostic performance is at an acceptable level. We explored the performance of the Panbio™ coronavirus disease-2019 antigen rapid diagnostic test in diagnosing the coronavirus disease-2019 infection.

Methods: A cross-sectional study was conducted on coronavirus disease-2019 suspected patients in Wollega University Referral Hospital, from 1 April to 30 May 2021. After obtaining consent/ assent, sociodemographic and pair of nasopharyngeal samples were collected from each and examined by Panbio antigen rapid diagnostic test and reverse transcription-polymerase chain reaction. Data were entered and analysed using SPSS version 24. Sensitivity, specificity, positive and negative predictive values, and kappa values were calculated.

Results: A total of 148 coronavirus disease-2019 suspected individuals (54.1% male) participated in the study. Of all, 73 (49.3%) were positive for severe acute respiratory syndrome corona virus by reverse transcription-polymerase chain reaction test. The sensitivity and specificity of Panbio were found 81% (95% confidence interval: 71%-91%) and 98.7% (95% confidence interval: 96%-100%), respectively. From 75 negative and 73 positive samples by reverse transcription-polymerase chain reaction, 1 (1.33%) and 14 (19.18%) were found false positive and negative by antigen rapid diagnostic test, respectively. Positive predictive value and negative predictive value of Panbio were 98.3% and 84.1%, respectively, and test agreement was substantial (kappa value = 0.80).

Conclusion: Panbio has fine performance in suspected patients. Further studies are needed to examine the accuracy of self-collecting and patient self-testing with healthcare workers, using antigen rapid diagnostic test against the reference standard.

Keywords: COVID-19; diagnostic performance; rapid antigen test; sensitivity; specificity.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

References

    1. Yek C, Warner S, Wiltz JL, et al.. Risk factors for severe COVID-19 outcomes among persons aged ⩾18 years who completed a primary COVID-19 vaccination series – 465 health care facilities, United States, December 2020-October 2021. MMWR Morb Mortal Wkly Rep 2022; 71(1): 19–25. - PMC - PubMed
    1. WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it. World Health Organization, 2021, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technica... (accessed 2 September 2021).
    1. Chen Y, Li Q, Karimian H, et al.. Spatio-temporal distribution characteristics and influencing factors of COVID-19 in China. Sci Rep 2021; 11(1): 3717. - PMC - PubMed
    1. Zhou L, Ayeh SK, Chidambaram V, et al.. Modes of transmission of SARS-CoV-2 and evidence for preventive behavioral interventions. BMC Infect Dis 2021; 21(1): 496. - PMC - PubMed
    1. WHO. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations scientific brief 29 March 2020. World Health Organization, 2021, https://www.who.int/news-room/commentaries/detail/modes-of-transmission-... (accessed 6 September 2021).

LinkOut - more resources